![](/img/cover-not-exists.png)
Pegylated interferon alfa-2a (PEGASYSTM) and ribavirin combination therapy for chronic hepatitis C: A phase II open-label study
Sulkowski, Mark S., Reindollar, Robert, Yu, J.Volume:
118
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(00)85944-2
Date:
April, 2000
File:
PDF, 190 KB
english, 2000